# COL25A1

## Overview
The COL25A1 gene encodes the collagen type XXV alpha 1 chain, a type II transmembrane protein that is predominantly expressed in neurons. This protein is part of the membrane-associated collagens with interrupted triple helices (MACITs) and plays a crucial role in neural development and function. It is involved in maintaining the structural integrity of neural tissues and is implicated in processes such as synapse formation, axon guidance, and neuronal migration. The collagen type XXV alpha 1 chain is particularly significant in the context of Alzheimer's disease, as it interacts with amyloid-beta (Aβ) peptides, contributing to amyloid plaque formation. This interaction is facilitated by specific binding motifs within the protein's structure, which also influences the expression of BACE1, a key enzyme in Aβ production. Additionally, variations in the COL25A1 gene have been associated with neuromuscular disorders, highlighting its broader clinical significance (Tong2009COL25A1; Langholm2019Type; Forsell2010Genetic).

## Structure
The COL25A1 gene encodes the collagen type XXV alpha 1 chain, a type II transmembrane protein specifically expressed in neurons. Its primary structure consists of three collagenous domains (COL1-3) interspersed with four noncollagenous domains (NC1-4) (Tong2009COL25A1). The NC1 domain includes a short cytoplasmic region, a transmembrane domain, and an extracellular ectodomain with a furin cleavage site, which is crucial for the protein's trafficking to cell membranes (Tong2009COL25A1). The NC2 domain contains a positively charged amino acid-rich motif that binds amyloid-beta (Aβ) and is predicted to bind heparin (Tong2009COL25A1). The NC3 domain features a coiled-coil motif necessary for forming the triple-helix structure of COL25A1 collagenous fibrils (Tong2009COL25A1).

The secondary structure of COL25A1 includes triple-helical regions, typical of collagen proteins. The tertiary structure involves a globular domain, while the quaternary structure may include trimeric assembly, allowing interaction with Aβ fibrils (Tong2009COL25A1). Post-translational modifications such as hydroxylation and glycosylation are common, contributing to the protein's stability and function. These structural features are significant for COL25A1's role in inducing BACE1 and its interaction with Aβ, contributing to Alzheimer's disease-like pathology (Tong2009COL25A1).

## Function
COL25A1 encodes collagen type XXV alpha 1 chain, a type II transmembrane protein primarily expressed in neurons. It is part of the membrane-associated collagens with interrupted triple helices (MACITs) and plays a significant role in neural development and function. In healthy human cells, COL25A1 is involved in maintaining the structure and function of neural tissues, influencing cognitive processes and neural plasticity (Langholm2019Type).

The protein is active in the extracellular matrix and is crucial for synapse formation and axon guidance, contributing to neuronal migration. It is predominantly expressed in brain regions associated with visual processing and the hippocampus, which are critical for memory and learning (Leggieri2022Neuronal; Langholm2019Type). COL25A1 is also expressed in the retina and enriched in retino-recipient nuclei within the brain, such as the suprachiasmatic nucleus and superior colliculus, suggesting its role in visual processing systems (Leggieri2022Neuronal).

In transgenic mice, overexpression of COL25A1 has been linked to increased amyloid β-peptide accumulation, indicating its involvement in amyloid plaque formation, a process associated with Alzheimer's disease pathology (Tong2009COL25A1). However, in healthy cells, COL25A1's interaction with amyloid β-peptides may help regulate fibril elongation and offer protection against amyloid β-mediated toxicity (Langholm2019Type).

## Clinical Significance
Mutations and alterations in the expression of the COL25A1 gene have been implicated in several neurological disorders, most notably Alzheimer's disease (AD). COL25A1 encodes the CLAC protein, which binds to amyloid-beta (Aβ) fibrils, a key component of amyloid plaques found in AD brains. Overexpression of COL25A1 in transgenic mice has been shown to lead to AD-like pathology, including amyloid accumulation, synaptic damage, and behavioral changes (Tong2009COL25A1). Genetic studies have identified single nucleotide polymorphisms (SNPs) within the COL25A1 gene that are associated with an increased risk of AD, particularly in familial and clinic-based cases (Forsell2010Genetic). These SNPs are located near the Aβ-binding motif, suggesting a direct role in amyloid plaque formation (Forsell2010Genetic).

In addition to its role in AD, variations in COL25A1 have been linked to congenital contractures and neuromuscular disorders. Patients with homozygous or compound heterozygous variations in COL25A1 exhibit a range of phenotypes, including joint contractures and respiratory muscle involvement, due to improper skeletal muscle innervation (Picker2023Features). These findings highlight the gene's involvement in both neurodegenerative and neuromuscular conditions.

## Interactions
COL25A1, encoding collagen type XXV alpha 1 chain, is involved in several interactions that are significant in the context of Alzheimer's disease and neuromuscular development. One of the primary interactions of COL25A1 is with amyloid-beta (Aβ) peptides. The protein binds to fibrilized Aβ, forming protease-resistant aggregates that contribute to senile plaque formation in Alzheimer's disease. This interaction is facilitated by a specific binding motif, LIKRRLIK, within the NC2 domain of COL25A1 (Langholm2019Type; Forsell2010Genetic). 

In Alzheimer's disease pathology, COL25A1 overexpression is associated with increased levels of BACE1, a key enzyme in Aβ production, and synaptophysin loss, indicating synaptic damage. The NC1, NC2, and NC3 domains of COL25A1 are crucial for inducing BACE1 expression, with the NC1 domain being essential for proper cellular localization (Tong2009COL25A1).

In neuromuscular development, COL25A1, also known as CLAC-P, interacts with extracellular matrix components like proteoglycans, similar to receptor protein tyrosine phosphatases (RPTPs), which are involved in axonal growth and regeneration. This interaction is crucial for motor nerve-muscle communication and motoneuron survival during early development (Tanaka2014CLACPCollagen).


## References


[1. (Leggieri2022Neuronal) Adele Leggieri, Chiara Attanasio, Antonio Palladino, Paolo de Girolamo, Carla Lucini, and Livia D’Angelo. Neuronal phenotype of col4a1 and col25a1: an intriguing hypothesis in vertebrates brain aging. International Journal of Molecular Sciences, 23(3):1778, February 2022. URL: http://dx.doi.org/10.3390/ijms23031778, doi:10.3390/ijms23031778. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23031778)

[2. (Langholm2019Type) L.L. Langholm, N.G. Kjeld, and M.A. Karsdal. Type XXV collagen, pages 191–196. Elsevier, 2019. URL: http://dx.doi.org/10.1016/b978-0-12-817068-7.00025-2, doi:10.1016/b978-0-12-817068-7.00025-2. This article has 0 citations.](https://doi.org/10.1016/b978-0-12-817068-7.00025-2)

[3. (Forsell2010Genetic) Charlotte Forsell, Behnosh Fakhri Björk, Lena Lilius, Karin Axelman, Susanne Froelich Fabre, Laura Fratiglioni, Bengt Winblad, and Caroline Graff. Genetic association to the amyloid plaque associated protein gene col25a1 in alzheimer’s disease. Neurobiology of Aging, 31(3):409–415, March 2010. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2008.04.009, doi:10.1016/j.neurobiolaging.2008.04.009. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neurobiolaging.2008.04.009)

[4. (Tanaka2014CLACPCollagen) Tomohiro Tanaka, Tomoko Wakabayashi, Hiroaki Oizumi, Shu Nishio, Takashi Sato, Akihiro Harada, Daisuke Fujii, Yuko Matsuo, Tadafumi Hashimoto, and Takeshi Iwatsubo. Clac-p/collagen type xxv is required for the intramuscular innervation of motoneurons during neuromuscular development. The Journal of Neuroscience, 34(4):1370–1379, January 2014. URL: http://dx.doi.org/10.1523/jneurosci.2440-13.2014, doi:10.1523/jneurosci.2440-13.2014. This article has 40 citations.](https://doi.org/10.1523/jneurosci.2440-13.2014)

[5. (Picker2023Features) Sarah MacKenzie Picker, George Parker, and Paul Gissen. Features of congenital arthrogryposis due to abnormalities in collagen homeostasis, a scoping review. International Journal of Molecular Sciences, 24(17):13545, August 2023. URL: http://dx.doi.org/10.3390/ijms241713545, doi:10.3390/ijms241713545. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241713545)

[6. (Tong2009COL25A1) Ying Tong, Ying Xu, Kimberly Scearce-Levie, Louis J. Ptáček, and Ying-Hui Fu. Col25a1 triggers and promotes alzheimer’s disease-like pathology in vivo. neurogenetics, 11(1):41–52, June 2009. URL: http://dx.doi.org/10.1007/s10048-009-0201-5, doi:10.1007/s10048-009-0201-5. This article has 59 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10048-009-0201-5)